Brillanz Pharma Private Limited - Company Profile

It is a pharma private limited company based in Kamothe, Maharashtra, India, established in 2017.
2017 Kamothe, Maharashtra, India Active
Last Updated:
Access Report
About Brillanz Pharma Private Limited

Brillanz Pharma Private Limited, a active private limited company, was established on 08 February 2017 in Kamothe, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2017PTC290928. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Prannoti Hemant Mote (Director), Deepali Manoj Tarate (Director). Its latest AGM occurred on 28 September 2023, with the balance sheet filed on 31 March 2023. It is based at Fl-D/303,Satyakunj Com, Plot No.41&42,Sector-3,, Kamothe, Maharashtra, 410209.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2017PTC290928

  • Registration Number

    290928

  • Incorporation Date

    08 February 2017

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 2 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** 529.78%
  • Profit Growth **** 45.15%
  • Ebitda **** 54.80%
  • Net Worth -15.35%
  • Total Assets **** 184.76%
Company report

Brillanz Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Brillanz Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Brillanz Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Prannoti Hemant Mote Director 08 Feb 2017 Current
Deepali Manoj Tarate Director 08 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Brillanz Pharma.

Brillanz Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 529.78% increase. The company also saw a substantial improvement in profitability, with a 45.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.35%.

Brillanz Pharma revenue growth over time
Brillanz Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 529.78%
*******
*******
*******
*******
Revenue from Operations
*******
 529.78%
*******
*******
*******
*******
Total Assets
*******
 184.76%
*******
*******
*******
*******
Profit or Loss
*******
 45.15%
*******
*******
*******
*******
Net Worth
*******
 -15.35%
*******
*******
*******
*******
EBITDA
*******
 54.80%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Brillanz Pharma?

In 2018, Brillanz Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Brillanz Pharma?

Unlock and access historical data on people associated with Brillanz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Brillanz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brillanz Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Brillanz Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Brillanz Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Brillanz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.

  • Director Appointment

    Prannoti Hemant Mote was appointed as a Director was appointed as a Director on 08 Feb 2017 & has been associated with this company since 9 years 2 days . was recorded as a recent event.

  • Director Appointment

    Progress on Deepali Manoj Tarate was appointed as a Director was appointed as a Director on 08 Feb 2017 & has been associated with this company since 9 years 2 days . was documented.

  • Company Incorporation

    The activity Brillanz Pharma Private Limited was registered on 08 Feb 2017 with Roc Mumbai & aged 9 years 2 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Brillanz Pharma Private Limited?

The CIN of Brillanz Pharma Private Limited is U74999MH2017PTC290928.

Where is Brillanz Pharma Private Limited headquartered?

Brillanz Pharma Private Limited is headquartered at Fl-D/303,Satyakunj Com, Plot No.41&42,Sector-3,, Kamothe, Maharashtra, 410209.

When was Brillanz Pharma Private Limited incorporated?

Brillanz Pharma Private Limited was incorporated on 08 February 2017.

Who are the current directors of Brillanz Pharma Private Limited?

The current directors of Brillanz Pharma Private Limited are

What is the primary industry of Brillanz Pharma Private Limited?

The primary industry of Brillanz Pharma Private Limited is Pharma.

Is Brillanz Pharma Private Limited a listed company?

Brillanz Pharma Private Limited is unlisted.

What is the capital structure of Brillanz Pharma Private Limited?

The authorized capital of Brillanz Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Brillanz Pharma Private Limited?

The compliance status of Brillanz Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available